FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio Palumbo

Research Profile

Disorders

Multiple Myeloma

Chemicals & Drugs

Procedures

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Antonio Palumbo; Chiara Cerrato
Diagnosis and therapy of multiple myeloma.
Antonio Palumbo; Roberto Mina
Management of older adults with multiple myeloma.
Antonio Palumbo; Roberto Mina
Part II: role of maintenance therapy in transplant-ineligible patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio Palumbo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Antonio Palumbo; Chiara Cerrato
Diagnosis and therapy of multiple myeloma.
The Korean journal of internal medicine 2013;28(3):263-73.
2013: Antonio Palumbo; Roberto Mina
Management of older adults with multiple myeloma.
Blood reviews 2013;27(3):133-42.
2013: Antonio Palumbo; Roberto Mina
Part II: role of maintenance therapy in transplant-ineligible patients.
Journal of the National Comprehensive Cancer Network : JNCCN 2013;11(1):43-9.
2012: Antonio Palumbo; Federica Cavallo
Have drug combinations supplanted stem cell transplantation in myeloma?
Blood 2012;120(24):4692-8.
2012: Antonio Palumbo
Optimizing multiple myeloma treatment: conclusions.
Leukemia research 2012;36 Suppl 1():S44-5.
2012: Antonio Palumbo; Ruben Niesvizky
Sustained disease control in transplant-ineligible patients: the role of continuous therapy.
Leukemia research 2012;36 Suppl 1():S19-26.
2012: Antonio Palumbo
Novel agents and the paradigm of continuous treatment in multiple myeloma.
Leukemia research 2012;36 Suppl 1():S1-2.
2012: Alessandra Larocca; Roberto Mina; Mario Boccadoro; Federica Cavallo; Antonio Palumbo
Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.
Future oncology (London, England) 2012;8(10):1223-38.
2012: Sara Bringhen; Chiara Cerrato; Francesca Gay; Mario Boccadoro; Chiara Pautasso; Antonio Palumbo
Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma.
Expert opinion on drug metabolism & toxicology 2012;8(9):1209-22.
2012: Massimo Offidani; Claudia Polloni; Stefano Pulini; Anna Marina Liberati; Francesco Alesiani; Stelvio Ballanti; Mario Boccadoro; Patrizia Caraffa; Massimo Catarini; Federica Cavallo; Laura Corvatta; Silvia Gentili; Pietro Leoni; Antonio Palumbo
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.
Leukemia & lymphoma 2012;53(9):1722-7.
2012: Antonio Palumbo
Transplantation for myeloma: work in progress.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(24):2935-6.
2012: Antonio Palumbo; Bruno Pontes; Pedro A V Reis de Souza; NB Viana; Leandro M Alves; Luciana Bueno Ferreira; Etel R P Gimba; Daniel Escorsim Machado; Felipe Leite de Oliveira; Celia Yelimar Palmero; Luiz E Nasciutti
Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
Cancer letters 2012;321(1):55-64.
2012: Michele Cavo; Claudia Crippa; Valerio De Stefano; Daniele Derudas; Maria Laura Dessanti; Daniela Donnarumma; Antonietta Falcone; Felicetto Ferrara; Anna Furlan; Mariella Grasso; Magda Marcatti; Luciano Masini; Pellegrino Musto; Andrea Nozza; Chiara Nozzoli; Antonio Palumbo; Lucia Pantani; Francesca Patriarca; Giulia Perrone; Maria Teresa Petrucci; Annalisa Pezzi; Elena Zamagni; Renato Zambello; Stelvio Ballanti; Anna Baraldi; Mario Boccadoro; Annamaria Brioli; Catello Califano; Vincenzo Callea; Angelo Michele Carella
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Blood 2012;120(1):9-19.
2012: Giovanni Barosi; Atto Billio; Mario Boccadoro; Michele Cavo; Paolo Corradini; Monia Marchetti; Massimo Massaia; Giampaolo Merlini; Antonio Palumbo; Patrizia Tosi; Sante Tura
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.
Annals of hematology 2012;91(6):875-88.
2012: Simone Ferrero; Francesco Forconi; Gianluca Gaidano; Valter Gattei; Daniela Gatti; Paola Ghione; Sara Barbiero; Francesco Bertoni; Mario Boccadoro; Michela Boi; Daniela Capello; Sergio Cortelazzo; Giovanni Del Poeta; Daniela Drandi; Alessandra Larocca; Luca Laurenti; Elisabetta Mantella; Barbara Mantoan; Marasca Roberto; Antonio Palumbo; Roberto Passera; Davide Rossi; Mirija Svaldi; Manuela Zanni; marco ladetto
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.
Haematologica 2012;97(6):849-53.
2012: Giovanni D'Arena; N Di Renzo; A Falcone; Felicetto Ferrara; R Guariglia; G Mansueto; M C Martorelli; Lucia Mastrullo; D Onofrillo; L Pagano; Antonio Palumbo; G Pietrantuono; G Semenzato; G Specchia; C G Valentini; A Venditti; O Villani; Pellegrino Musto
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1499-502.
2012: Antonio Palumbo; Maria Teresa Petrucci; Torben Plesner; Joergen Radke; Ivan Spicka; Katja Weisel; Wiesław Wiktor-Jędrzejczak; Zhinuan Yu; Mamia Zodelava; Meral Beksac; Dina Ben Yehuda; Joan Bladé; Nicola Cascavilla; John Catalano; Michele Cavo; Alessandro Corso; Michel Delforge; Meletios A Dimopoulos; Heinz Gisslinger; Roman Hajek; Lindsay Herbein; Genadi Iosava; Christian Jacques; Janusz Kloczko; Martin Kropff; Christian Langer; Jay Mei
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
The New England journal of medicine 2012;366(19):1759-69.
2012: Gareth Morgan; Antonio Palumbo; Pieter Sonneveld; Andrew Spencer; Ingemar Turesson; Anders Waage; Hans Erik Johnsen; Heinz Ludwig; Jesus San Miguel; Paul Browne; Michele Cavo; Char Sang Chim; Hermann Einsele; Hartmut Goldschmidt; Roman Hajek; Kari Hemminki; richard Houlston
MyelomA Genetics International Consortium.
Leukemia & lymphoma 2012;53(5):796-800.
2012: Pellegrino Musto; Antonino Neri; Massimo Offidani; Paola Omede'; Livio Pagano; Maria Teresa Petrucci; Patrizia Tosi; Luca Baldini; Mario Boccadoro; Giovanni Battista Bochicchio; Sara Bringhen; Tommaso Caravita; Michele Cavo; Fiorella D'Auria; Francesco Di Raimondo; Fortunato Morabito; Antonio Palumbo
Primary plasma cell leukemia in the era of new drugs: has something changed?
Critical reviews in oncology/hematology 2012;82(2):141-9.
2012: Paul G Richardson; O Sezer; D Siegel; E Terpos; S Usmani; D Vesole; P Voorhees; P Wen; Kenneth C Anderson; H Avet-Loiseau; M Beksac; J Bladé; M Cavo; W J Chng; R Comenzo; M Delforge; M Dimopoulos; B G M Durie; H Einsele; Jean-Luc Harousseau; Sundar Jagannath; J L Jongen; J J Lahuerta; J H Lee; Sagar Lonial; M-V Mateos; A Mazumder; G Merlini; J San Miguel; P Moreau; G Morgan; N Munshi; R Niesvizky; Robert Z Orlowski; Antonio Palumbo; S V Rajkumar; Pieter Sonneveld
Management of treatment-emergent peripheral neuropathy in multiple myeloma.
Leukemia 2012;26(4):595-608.
2012: Heinz Ludwig; Maria-Victoria Mateos; Philip McCarthy; Gareth Morgan; Ruben Niesvizky; Robert Z Orlowski; Antonio Palumbo; Paul G Richardson; Jésus San Miguel; Pieter Sonneveld; Andrew Spencer; Keith A Stewart; Anders Waage; Pierre Wijermans; Kenneth C Andersen; Michel Attal; Bart Barlogie; Meral Beksac; P Leif Bergsagel; Michele Cavo; Brian G M Durie; Hermann Einsele; Thierry Facon; Axel Hinke; Cyrille Hulin; Ola Landgren; Henk Lokhorst
IMWG consensus on maintenance therapy in multiple myeloma.
Blood 2012;119(13):3003-15.
2012: Alessandro Gozzetti; Francesco Lauria; Flavia Lotti; Pellegrino Musto; Chiara Nozzoli; Massimo Offidani; Antonio Palumbo; Francesca Patriarca; Maria Teresa Petrucci; Davide Rossi; Roberto Vallone; Stelvio Ballanti; Alberto Fabbri; Monica Galli; Elena Marchini; Giuseppe Mele; Stefania Oliva; Maria Teresa Pirrotta; Fabiana Gentillini Sapienza; Elena Zamagni; Salvatore Berretta; Michele Cavo; Alfonso CERASE; Michele Floridia; Francesco Di Raimondo
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.
Cancer 2012;118(6):1574-84.
2012: Tommasina Guglielmelli; Sara Bringhen; Antonio Palumbo
Update on the use of defibrotide.
Expert opinion on biological therapy 2012;12(3):353-61.
2012: Silvia Mangiacavalli; Antonio Palumbo; Cristiana Pascutto; Patrizia Zappasodi; Giovanni Albani; Sara Bringhen; Tommaso Caravita; Mario Cazzola; Federica Cocito; Alessandro Corso
Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma.
Leukemia & lymphoma 2012;53(3):514-5.
2012: Antonio Palumbo; Orhan Sezer; Pieter Sonneveld; Andrew Spencer; Jon Bladé; Mario Boccadoro; Faith Davies; Meletios Dimopoulos; Anna Dmoszynska; Hermann Einsele; Philippe Moreau; Carmela Palladino; Jesus San Miguel
How to manage neutropenia in multiple myeloma.
Clinical lymphoma, myeloma & leukemia 2012;12(1):5-11.
2012: Alessandra Larocca; Arnon Nagler; Francesca Patriarca; Jacopo Peccatori; Maria Teresa Petrucci; Sara Pezzatti; Agostina Siniscalchi; Anfisa Stanevsky; Dina Ben Yehuda; Eloise Beggiato; Mario Boccadoro; Sara Bringhen; Anna Maria Cafro; Angelo Michele Carella; Lucio Catalano; Maide Cavalli; Federica Cavallo; Michele Cavo; Paolo Corradini; Claudia Crippa; Francesco Di Raimondo; Tommaso Caravita Di Toritto; Andrea Evangelista; Anna Falanga; Antonio Palumbo
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Blood 2012;119(4):933-9; quiz 1093.
2012: Antonio Palumbo; Federica Cavallo
Have drug combinations supplanted stem cell transplantation in myeloma?
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012;2012():335-41.
2012: Barbara Lupo; Antonio Palumbo
Lenalidomide in the treatment of young patients with multiple myeloma: from induction to consolidation/maintenance therapy.
Advances in hematology 2012;2012():906247.
2012: Heinz Ludwig; Ulf-Henrik Mellqvist; Philippe Moreau; Jesús San-Miguel; Pia Sondergeld; Pieter Sonneveld; Miklos Udvardy; Hervé Avet-Loiseau; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Michele Cavo; Faith Davies; Javier de la Rubia; Sosana Delimpasi; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Urs Hess; Antonio Palumbo
European perspective on multiple myeloma treatment strategies: update following recent congresses.
The oncologist 2012;17(5):592-606.
2012: Antonio Palumbo
Multiple myeloma.
Current opinion in oncology 2012;24 Suppl 2():S1-2.
2012: Antonio Palumbo; Lilia Weiss; John Freeman; Pierre Fenaux
The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes.
Expert opinion on drug safety 2012;11(1):107-20.
2012: Shaji Kumar; J J Lahuerta; J H Lee; X LeLeu; J S Miguel; P Moreau; G Morgan; Robert Z Orlowski; Antonio Palumbo; S Vincent Rajkumar; Paul G Richardson; O Sezer; D Siegel; Pieter Sonneveld; Joan Bladé; John Crowley; B G M Durie; J Feather; H Goldschmidt; Jeffrey Haessler; Antje Hoering; C Hulin; Sundar Jagannath; S K Klein
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.
Leukemia 2012;26(1):149-57.
2012: C L Echart; J Fareed; Antonio Palumbo; Paul G Richardson; S Somaini; M Distaso; M Iacobelli
Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cells.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(1):79-86.
2011: Luca Agnelli; Marina Bolzoni; Benedetta Dalla Palma; Antonino Neri; Antonio Palumbo; Francesco Piazza; Alberto Rocci; Gabriella Sammarelli; Gianpietro Semenzato; Paola Storti; Katia Todoerti; Nicola Giuliani
Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations.
American journal of hematology 2011;86(12):E64-6.
2011: Fortunato Morabito; Caterina Musolino; Pellegrino Musto; Chiara Nozzoli; Massimo Offidani; Francesca Patriarca; Maria Teresa Petrucci; Roberto Ria; Davide Rossi; Iolanda Vincelli; Luca Baldini; Giulia Benevolo; Mario Boccadoro; Sara Bringhen; Nicola Cascavilla; Michele Cavo; Francesco Di Raimondo; Massimo Gentile; Mariella Grasso; Tommasina Guglielmelli; Ignazio Majolino; Marasca Roberto; Carla Mazzone; Vittorio Montefusco; Antonio Palumbo
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
Blood 2011;118(22):5759-66.
2011: Antonio Palumbo; Laura Rosiñol; Jesus F San Miguel; Orhan Sezer; Andrew Spencer; Evangelos Terpos; Sonja Zweegman; Meral Beksac; Joan Bladé; Mario Boccadoro; Sara Bringhen; Michele Cavo; Faith Davies; Meletios A Dimopoulos; Christoph Driessen; Hermann Einsele; Peter Gimsing; Martin Gramatzki; Roman Hàjek; Hans E Johnsen; Fernando Leal Da Costa; Henk Lokhorst; Heinz Ludwig; Maria V Mateos; Gareth Morgan; Pieter Sonneveld
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Blood 2011;118(17):4519-29.
2011: Alessandra Larocca; Antonio Palumbo
Evolving paradigms in the treatment of newly diagnosed multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(10):1186-96.
2011: F Cavallo; C Crippa; A M Liberati; B Lupo; Giuseppe Milone; Vittorio Montefusco; Pellegrino Musto; A Nagler; Paola Omedè; D Ben-Yehuda; Mario Boccadoro; Sara Bringhen; Anna Maria Cafro; E Calabrese; Tommaso Caravita; Angelo Michele Carella; N Cascavilla; L Catalano; Roberto Passera; Francesca Patriarca; Jacopo Peccatori; Maria Teresa Petrucci; F Rossini; Antonio Palumbo
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy.
Leukemia 2011;25(10):1627-31.
2011: Barbara Castella; Marta Coscia; Francesca Fiore; Myriam Foglietta; Antonio Palumbo; Francesca Pantaleoni; Silvia Peola; Chiara Riganti; Mario Boccadoro; Amalia Bosia; Maria Elisa Canepari; Massimo Massaia
Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(4):1578-90.
2011: Peter M Fayers; Peter Gimsing; Rauf Haznedar; Cyrille Hulin; Jean-Yves Mary; Philippe Moreau; Pellegrino Musto; Antonio Palumbo; Martijn Schaafsma; Pieter Sonneveld; Fabian Termorshuizen; Ingemar Turesson; Anders Waage; Pierre Wijermans; Meral Beksaç; Lotfi Benboubker; Sara Bringhen; Tommaso Caravita; Thierry Facon
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.
Blood 2011;118(5):1239-47.
2011: Antonio Palumbo; Sara Bringhen; Maria-Victoria Mateos; Jesús F San Miguel
Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?
Blood reviews 2011;25(4):181-91.
2011: Luisa Giaccone; Ted A Gooley; Alessandro Levis; Massimo Massaia; Nicola Mordini; Paola Omedè; Antonio Palumbo; Francesca Patriarca; Marcello Rotta; Roberto Sorasio; Rainer Storb; Barry Storer; Massimo Aglietta; Bernardino Allione; Mario Boccadoro; Sara Bringhen; Lucia Brunello; Fabrizio Carnevale-Schianca; Giovannino Ciccone; Renato Fanin; Moreno Festuccia; Andrea Gallamini; Benedetto Bruno
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.
Blood 2011;117(24):6721-7.
2011: Michele Cavo; Meletios A Dimopoulos; Brian G M Durie; Hermann Einsele; Gösta Gahrton; Sundar Jagannath; Hans E Johnsen; Nicolaus Kroeger; Sagar Lonial; Heinz Ludwig; Philippe Moreau; Ruben Niesvizky; Robert Z Orlowski; Antonio Palumbo; S Vincent Rajkumar; Paul G Richardson; Jesus San Miguel; Orhan Sezer; Pieter Sonneveld; David H Vesole; Kenneth C Anderson; Michel Attal; William Bensinger; P Leif Bergsagel; Joan Bladé; Mario Boccadoro
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Blood 2011;117(23):6063-73.
2011: Benedetto Bruno; Francesca Gay; Mario Boccadoro; Antonio Palumbo
Management of myeloma: an Italian perspective.
Clinical lymphoma, myeloma & leukemia 2011;11 Suppl 1():S82-6.
2011: Massimo Offidani; Laura Corvatta; Fortunato Morabito; Massimo Gentile; Pellegrino Musto; Pietro Leoni; Antonio Palumbo
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions.
Expert opinion on investigational drugs 2011;20(6):779-93.
2011: Niels W C J van de Donk; Henk M Lokhorst; Meletios Dimopoulos; Michele Cavo; Gareth Morgan; Hermann Einsele; Martin Kropff; Steve Schey; Hervé Avet-Loiseau; Heinz Ludwig; Hartmut Goldschmidt; Pieter Sonneveld; Hans E Johnsen; Joan Bladé; Jesús F San Miguel; Antonio Palumbo
Treatment of relapsed and refractory multiple myeloma in the era of novel agents.
Cancer treatment reviews 2011;37(4):266-83.
2011: Nikhil C Munshi; Antonio Palumbo; S Vincent Rajkumar; Jesus San Miguel; Orhan Sezer; John Shaughnessy; Pieter Sonneveld; A Keith Stewart; Kenneth C Anderson; Hervé Avet-Loiseau; P Leif Bergsagel; Michele Cavo; John Crowley; Meletios Dimopoulos; Brian Durie; Rafael Fonseca; Roman Hajek; Jean-Luc Harousseau; Sundar Jagannath; Robert Kyle
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.
Blood 2011;117(18):4696-700.
2011: S Vincent Rajkumar; Paul Richardson; Jesús San Miguel; Orhan Sezer; David Siegel; David H Vesole; Jeffrey A Zonder; Kenneth C Anderson; Hervé Avet-Loiseau; Joan Blade; Meletios Dimopoulos; Brian G M Durie; Thierry Facon; Jean-Luc Harousseau; Sundar Jagannath; Robert Kyle; Sagar Lonial; Heinz Ludwig; Nikhil C Munshi; Robert Z Orlowski; Antonio Palumbo
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Blood 2011;117(18):4691-5.
2011: Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca Gay; Barbara Botto; Chiara Frairia; Andrea Evangelista; Fortunato Morabito; Mario Boccadoro; Umberto Vitolo; Antonio Palumbo
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens.
Cancer 2011;117(9):1884-90.
2011: Meletios A Dimopoulos; Antonio Palumbo; M Attal; M Beksaç; F E Davies; M Delforge; H Einsele; R Hajek; Jean-Luc Harousseau; F Leal da Costa; Heinz Ludwig; U-H Mellqvist; G J Morgan; J F San-Miguel; S Zweegman; Pieter Sonneveld
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.
Leukemia 2011;25(5):749-60.
2011: Tommasina Guglielmelli; Sara Bringhen; S Rrodhe; Francesca Gay; Federica Cavallo; Alfredo Berruti; Vittorio Montefusco; E Piro; G Benevolo; Maria Teresa Petrucci; Tommaso Caravita; M Offidani; Paolo Corradini; Mario Boccadoro; Giuseppe Saglio; Antonio Palumbo
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients.
European journal of cancer (Oxford, England : 1990) 2011;47(6):814-8.
2011: Antonio Palumbo; Kenneth C Anderson
Multiple myeloma.
The New England journal of medicine 2011;364(11):1046-60.
2011: Francesca Gay; Alessandra Larocca; Pierre Wijermans; Federica Cavallo; Davide Rossi; Ron Schaafsma; Mariella Genuardi; Alessandra Romano; Anna Marina Liberati; Agostina Siniscalchi; Maria Teresa Petrucci; Chiara Nozzoli; Francesca Patriarca; Massimo Offidani; Roberto Ria; Paola Omedè; Benedetto Bruno; Roberto Passera; Pellegrino Musto; Mario Boccadoro; Pieter Sonneveld; Antonio Palumbo
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients.
Blood 2011;117(11):3025-31.
2011: Antonio Palumbo; Michel Attal; Murielle Roussel
Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(6):1253-63.
2011: Antonio Palumbo; Michele Cavo; Sara Bringhen; Elena Zamagni; Alessandra Romano; Francesca Patriarca; Davide Rossi; Fabiana Gentilini; Claudia Crippa; Monica Galli; Chiara Nozzoli; Roberto Ria; Marasca Roberto; Vittorio Montefusco; Luca Baldini; Francesca Elice; Vincenzo Callea; Stefano Pulini; Angelo M Carella; Renato Zambello; Giulia Benevolo; Valeria Magarotto; Paola Tacchetti; Norbert Pescosta; Claudia Cellini; Claudia Polloni; Andrea Evangelista; Tommaso Caravita; Fortunato Morabito; Massimo Offidani; Patrizia Tosi; Mario Boccadoro
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(8):986-93.
2011: Antonio Palumbo; Francesca Gay
A new combination for advanced multiple myeloma.
The lancet oncology 2011;12(3):207-8.
2011: Francesca Gay; Antonio Palumbo
Management of older patients with multiple myeloma.
Blood reviews 2011;25(2):65-73.
2011: Antonio Palumbo; Valeria Magarotto
Novel treatment paradigm for elderly patients with multiple myeloma.
American journal of blood research 2011;1(2):190-204.
2011: Heinz Ludwig; Meral Beksac; Joan Bladé; Jamie Cavenagh; Michele Cavo; Michel Delforge; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Jean-Luc Harousseau; Urs Hess; Martin Kropff; Fernando Leal da Costa; Vernon Louw; Hila Magen-Nativ; Larisa Mendeleeva; Hareth Nahi; Torben Plesner; Jesús San-Miguel; Pieter Sonneveld; Miklos Udvardy; Pia Sondergeld; Antonio Palumbo
Multiple myeloma treatment strategies with novel agents in 2011: a European perspective.
The oncologist 2011;16(4):388-403.
2011: Tommasina Guglielmelli; Maria Teresa Petrucci; Giuseppe Saglio; Antonio Palumbo
Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patients.
British journal of haematology 2011;152(1):108-10.
2011: Meletios A Dimopoulos; Maria-Victoria Mateos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Antonio Palumbo; Ka Lung Wu; Dixie Esseltine; Kevin Liu; William Deraedt; Andrew Cakana; Helgi Van De Velde; Jesús F San Miguel
Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.
European journal of haematology 2011;86(1):23-31.
2010: Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia Pantani; Monica Galli; Francesco Di Raimondo; Claudia Crippa; Elena Zamagni; Antonio Palumbo; Massimo Offidani; Paolo Corradini; Franco Narni; Antonio Spadano; Norbert Pescosta; Giorgio Lambertenghi Deliliers; Antonio Ledda; Claudia Cellini; Tommaso Caravita; Patrizia Tosi; Michele Baccarani
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
Lancet 2010;376(9758):2075-85.
2010: Sara Bringhen; Alessandra Larocca; Davide Rossi; Maide Cavalli; Mariella Genuardi; Roberto Ria; Silvia Gentili; Francesca Patriarca; Chiara Nozzoli; Anna Levi; Tommasina Guglielmelli; Giulia Benevolo; Vincenzo Callea; Vincenzo Rizzo; Clotilde Cangialosi; Pellegrino Musto; Luca De Rosa; Anna Marina Liberati; Mariella Grasso; Antonietta Falcone; Andrea Evangelista; Michele Cavo; Gianluca Gaidano; Mario Boccadoro; Antonio Palumbo
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.
Blood 2010;116(23):4745-53.
2010: Antonio Palumbo; Sara Bringhen; Davide Rossi; Maide Cavalli; Alessandra Larocca; Roberto Ria; Massimo Offidani; Francesca Patriarca; Chiara Nozzoli; Tommasina Guglielmelli; Giulia Benevolo; Vincenzo Callea; Luca Baldini; Fortunato Morabito; Mariella Grasso; Giovanna Leonardi; Manuela Rizzo; Antonietta Pia Falcone; Daniela Gottardi; Vittorio Montefusco; Pellegrino Musto; Maria Teresa Petrucci; Giovannino Ciccone; Mario Boccadoro
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(34):5101-9.
2010: Meletios A Dimopoulos; Evangelos Terpos; Asher Chanan-Khan; Nelson Leung; Heinz Ludwig; Sundar Jagannath; Ruben Niesvizky; Sergio Giralt; Jean-Paul Fermand; Joan Bladé; Raymond L Comenzo; Orhan Sezer; Antonio Palumbo; Jean-Luc Harousseau; Paul G Richardson; Bart Barlogie; Kenneth C Anderson; Pieter Sonneveld; Patrizia Tosi; Michele Cavo; S Vincent Rajkumar; Brian G M Durie; Jésus San Miguel
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4976-84.
2010: Jean-Luc Harousseau; Antonio Palumbo; Paul G Richardson; Rudolf Schlag; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Alain Kentos; Michele Cavo; Anatoly Golenkov; Mieczyslaw Komarnicki; Maria-Victoria Mateos; Dixie Esseltine; Andrew Cakana; Kevin Liu; William Deraedt; Helgi van de Velde; Jesús F San Miguel
Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone.
Blood 2010;116(19):3743-50.
2010: Michel Delforge; Joan Bladé; Meletios A Dimopoulos; Thierry Facon; Martin Kropff; Heinz Ludwig; Antonio Palumbo; Philip Van Damme; Jesús F San Miguel; Pieter Sonneveld
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues.
The lancet oncology 2010;11(11):1086-95.
2010: Monika Engelhardt; Josefina Udi; Martina Kleber; Andrew Spencer; Alberto Rocci; Stefan Knop; Benedetto Bruno; Sara Bringhen; José A Pérez-Simón; Sonja Zweegman; Christoph Driessen; Francesca Patriarca; Martin Gramatzki; Evangelos Terpos; Orhan Sezer; Martin Kropff; Christian Straka; Hans E Johnsen; Anders Waage; Martin Boegsted; Henk Lokhorst; Roman Hájek; Gareth Morgan; Mario Boccadoro; Heinz Ludwig; Michele Cavo; Aaron Polliack; Pieter Sonneveld; Hermann Einsele; Antonio Palumbo
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.
Leukemia & lymphoma 2010;51(11):2006-11.
2010: Flavia Pichiorri; Sung-Suk Suh; Alberto Rocci; Luciana De Luca; Cristian Taccioli; Ramasamy Santhanam; Wenchao Zhou; Don M Benson; Craig Hofmainster; Hansjuerg Alder; Michela Garofalo; Gianpiero Di Leva; Stefano Volinia; Huey-Jen Lin; Danilo Perrotti; Michael Kuehl; Rami I Aqeilan; Antonio Palumbo; Carlo M Croce
Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.
Cancer cell 2010;18(4):367-81.
2010: Massimo Offidani; Pietro Leoni; Laura Corvatta; Claudia Polloni; Silvia Gentili; Anna Marina Liberati; Stefano Pulini; Alessandro Gozzetti; Stelvio Ballanti; Chiara Nozzoli; Antonio Palumbo
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trials.
Clinical lymphoma, myeloma & leukemia 2010;10(5):353-60.
2010: Evangelos Terpos; Meletios A Dimopoulos; O Sezer; D Roodman; N Abildgaard; R Vescio; P Tosi; R Garcia-Sanz; F Davies; A Chanan-Khan; Antonio Palumbo; Pieter Sonneveld; M T Drake; Jean-Luc Harousseau; Kenneth C Anderson; B G M Durie
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Leukemia 2010;24(10):1700-12.
2010: Antonio Palumbo
Balancing act for elderly myeloma.
Blood 2010;116(9):1390-1.
2010: Fortunato Morabito; Massimo Gentile; Carla Mazzone; Sara Bringhen; Ernesto Vigna; Eugenio Lucia; Anna Grazia Recchia; Francesco D Raimondo; Pellegrino Musto; Antonio Palumbo
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs.
European journal of haematology 2010;85(3):181-91.
2010: Francesca Gay; S Vincent Rajkumar; Patrizia Falco; Shaji Kumar; Angela Dispenzieri; Maria Teresa Petrucci; Morie A Gertz; Mario Boccadoro; A Keith Stewart; Antonio Palumbo
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.
European journal of haematology 2010;85(3):200-8.
2010: Francesca Gay; Antonio Palumbo
Multiple myeloma: management of adverse events.
Medical oncology (Northwood, London, England) 2010;27(3):646-53.
2010: Antonio Palumbo
First-line treatment of elderly multiple myeloma patients.
Clinical advances in hematology & oncology : H&O 2010;8(8):529-30.
2010: Antonio Palumbo
Hematology: Is thalidomide combination a new option for myeloma?
Nature reviews. Clinical oncology 2010;7(8):425-6.
2010: Monika Engelhardt; Martina Kleber; Josefina Udi; Ralph Wäsch; Andrew Spencer; Francesca Patriarca; Stefan Knop; Benedetto Bruno; Martin Gramatzki; Fortunato Morabito; Martin Kropff; Antonino Neri; Orhan Sezer; Rom Hajek; Donald Bunjes; Mario Boccadoro; Christian Straka; Michele Cavo; Aaron Polliack; Hermann Einsele; Antonio Palumbo
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.
Leukemia & lymphoma 2010;51(8):1424-43.
2010: Massimo Offidani; Pietro Leoni; Sara Bringhen; Laura Corvatta; Alessandra Larocca; Silvia Gentili; Stefania Oliva; Claudia Polloni; Piero Galieni; Massimo Catarini; Francesco Alesiani; Anna Mele; Marino Brunori; Nicola Blasi; Mario Ferranti; Giuseppe Visani; Mario Boccadoro; Antonio Palumbo
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.
Leukemia & lymphoma 2010;51(8):1444-9.
2010: Antonio Palumbo; F Davies; M Kropff; J Bladé; M Delforge; F Leal da Costa; R Garcia Sanz; S Schey; Thierry Facon; G Morgan; P Moreau
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma.
Annals of hematology 2010;89(8):803-11.
2010: James R Berenson; Kenneth C Anderson; Robert A Audell; Ralph V Boccia; Morton Coleman; Meletios A Dimopoulos; Matthew T Drake; Rafael Fonseca; Jean-Luc Harousseau; Douglas Joshua; Sagar Lonial; Ruben Niesvizky; Antonio Palumbo; G David Roodman; Jesus F San-Miguel; Seema Singhal; Donna M Weber; Maurizio Zangari; Eric Wirtschafter; Ori Yellin; Robert A Kyle
Monoclonal gammopathy of undetermined significance: a consensus statement.
British journal of haematology 2010;150(1):28-38.
2010: Nicola Giuliani; Gina Lisignoli; F Novara; P Storti; N Zaffaroni; R Villa; Gabriella Sammarelli; Luca Agnelli; Katia Todoerti; M E Bernardo; C Manferdini; Simona Colla; M Abeltino; M Bolzoni; A Rocci; E Gabusi; Antonio Palumbo; O Zuffardi; A Neri; Vittorio Rizzoli
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients.
Leukemia 2010;24(7):1368-70.
2010: Antonio Palumbo; Alessandra Larocca; Mariella Genuardi; Katarzyna Kotwica; Francesca Gay; Davide Rossi; Giulia Benevolo; Valeria Magarotto; Federica Cavallo; Sara Bringhen; Cecilia Rus; Luciano Masini; Massimo Iacobelli; Gianluca Gaidano; Constantine Mitsiades; Kenneth C Anderson; Mario Boccadoro; Paul G Richardson
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial.
Haematologica 2010;95(7):1144-9.
2010: Francesca Gay; Antonio Palumbo
Management of disease- and treatment-related complications in patients with multiple myeloma.
Medical oncology (Northwood, London, England) 2010;27 Suppl 1():S43-52.
2010: Robert A Kyle; Brian G M Durie; S Vincent Rajkumar; Ola Landgren; Joan Blade; Giampaolo Merlini; N Kröger; Hermann Einsele; David H Vesole; M Dimopoulos; Jesús San Miguel; Hervé Avet-Loiseau; R Hajek; W M Chen; Kenneth C Anderson; Heinz Ludwig; Pieter Sonneveld; Santiago Pavlovsky; Antonio Palumbo; Paul G Richardson; Bart Barlogie; Philip R Greipp; R Vescio; I Turesson; Jan Westin; Mario Boccadoro
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Leukemia 2010;24(6):1121-7.
2010: Antonio Palumbo; A Larocca; Patrizia Falco; G Sanpaolo; Antonietta Falcone; V Federico; L Canepa; monica crugnola; M Genuardi; V Magarotto; Maria Teresa Petrucci; Mario Boccadoro
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma.
Leukemia 2010;24(5):1037-42.
2010: Maria-Victoria Mateos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Maria T Petrucci; Antonio Palumbo; Olga S Samoilova; Anna Dmoszynska; Kudrat M Abdulkadyrov; Rik Schots; Bin Jiang; Dixie Esseltine; Kevin Liu; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2259-66.
2010: Antonio Palumbo; S Vincent Rajkumar
Multiple myeloma: chemotherapy or transplantation in the era of new drugs.
European journal of haematology 2010;84(5):379-90.
2010: marco ladetto; Gloria Pagliano; Simone Ferrero; Federica Cavallo; Daniela Drandi; Loredana Santo; Claudia Crippa; Luca De Rosa; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Vincenzo Callea; Pellegrino Musto; Clotilde Cangialosi; Roberto Passera; Mario Boccadoro; Antonio Palumbo
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2077-84.
2010: Antonio Palumbo
Early response predicts myeloma outcome.
Blood 2010;115(12):2332-3.
2010: Heinz Ludwig; Vanessa Bolejack; John Crowley; Joan Bladé; Jesus San Miguel; Robert A Kyle; S Vincent Rajkumar; Kazuyuki Shimizu; Ingemar Turesson; Jan Westin; Pieter Sonneveld; Michele Cavo; Mario Boccadoro; Antonio Palumbo; Patrizia Tosi; Jean-Luc Harousseau; Michel Attal; Bart Barlogie; A Keith Stewart; Brian G M Durie
Survival and years of life lost in different age cohorts of patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1599-605.
2010: Antonio Palumbo; Sara Bringhen; Benedetto Bruno; Antonietta Pia Falcone; Anna Marina Liberati; Mariella Grasso; Roberto Ria; Francesco Pisani; Clotilde Cangialosi; Tommaso Caravita; Anna Levi; Giovanna Meloni; Andrea Nozza; Patrizia Pregno; Attilio Gabbas; Vincenzo Callea; Manuela Rizzo; Luciana Annino; Valerio De Stefano; Pellegrino Musto; Ileana Baldi; Federica Cavallo; Maria Teresa Petrucci; Massimo Massaia; Mario Boccadoro
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.
Blood 2010;115(10):1873-9.
2010: Fortunato Morabito; Massimo Gentile; Stefania Ciolli; Maria T Petrucci; Sara Galimberti; Giuseppe Mele; Antonio F Casulli; Donato Mannina; Eugenio Piro; Graziella Pinotti; Salvatore Palmieri; Lucio Catalano; Vincenzo Callea; Massimo Offidani; Pellegrino Musto; Sara Bringhen; Luca Baldini; Patrizia Tosi; Francesco Di Raimondo; Mario Boccadoro; Antonio Palumbo; Michele Cavo
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.
European journal of haematology 2010;84(3):223-8.
2010: Antonio Palumbo; Francesca Gay; Patrizia Falco; Claudia Crippa; Vittorio Montefusco; Francesca Patriarca; Fausto Rossini; Simona Caltagirone; Giulia Benevolo; Norbert Pescosta; Tommasina Guglielmelli; Sara Bringhen; Massimo Offidani; Nicola Giuliani; Maria Teresa Petrucci; Pellegrino Musto; Anna Marina Liberati; Giuseppe Rossi; Paolo Corradini; Mario Boccadoro
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):800-7.
2010: Sundar Jagannath; Robert A Kyle; Antonio Palumbo; David S Siegel; Sonia Cunningham; James Berenson
The current status and future of multiple myeloma in the clinic.
Clinical lymphoma, myeloma & leukemia 2010;10(1):28-43.
2010: Heinz Ludwig; Meral Beksac; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Michele Cavo; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Jean-Luc Harousseau; Urs Hess; Nicolas Ketterer; Martin Kropff; Larisa Mendeleeva; Gareth Morgan; Antonio Palumbo; Torben Plesner; Jesús San Miguel; Ofer Shpilberg; Pia Sondergeld; Pieter Sonneveld; Sonja Zweegman
Current multiple myeloma treatment strategies with novel agents: a European perspective.
The oncologist 2010;15(1):6-25.
2010: Antonio Palumbo; Francesca Gay
Towards a new standard of care for patients with myeloma?
The lancet oncology 2010;11(1):3-4.
2009: Valeria Magarotto; Antonio Palumbo
Evolving role of novel agents for maintenance therapy in myeloma.
Cancer journal (Sudbury, Mass.) 2009;15(6):494-501.
2009: Pellegrino Musto; Fiorella D'Auria; Giuseppe Pietrantuono; Luca Baldini; Sara Bringhen; Tommaso Caravita; Francesco Di Raimondo; Fortunato Morabito; Massimo Offidani; Maria Teresa Petrucci; Patrizia Tosi; Francesca Gay; Michele Cavo; Mario Boccadoro; Antonio Palumbo
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective.
Current drug targets 2009;10(10):906-22.
2009: Sergio Giralt; E A Stadtmauer; Jean-Luc Harousseau; Antonio Palumbo; W Bensinger; R L Comenzo; S Kumar; N C Munshi; A Dispenzieri; R Kyle; G Merlini; J San Miguel; Heinz Ludwig; R Hajek; Sundar Jagannath; J Blade; Sagar Lonial; M A Dimopoulos; H Einsele; Bart Barlogie; Kenneth C Anderson; M Gertz; M Attal; P Tosi; Pieter Sonneveld; Mario Boccadoro; G Morgan; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; Wesley Chen; K Shimizu; R Powles; Paul G Richardson; R Niesvizky; S V Rajkumar; B G M Durie
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
Leukemia 2009;23(10):1904-12.
2009: Antonio Palumbo; O Sezer; R Kyle; J S Miguel; Robert Z Orlowski; P Moreau; R Niesvizky; G Morgan; R Comenzo; Pieter Sonneveld; S Kumar; R Hajek; Sergio Giralt; S Bringhen; Kenneth C Anderson; Paul G Richardson; M Cavo; F Davies; J Bladé; H Einsele; M A Dimopoulos; A Spencer; A Dispenzieri; T Reiman; K Shimizu; J H Lee; M Attal; Mario Boccadoro; M Mateos; W Chen; Heinz Ludwig; D Joshua; J Chim; V Hungria; I Turesson; B G M Durie; Sagar Lonial
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
Leukemia 2009;23(10):1716-30.
2009: Alessandro Corso; Patrizia Zappasodi; Luciana Barbarano; Maria Teresa Petrucci; Antonio Palumbo; Tommaso Caravita; Silvia Mangiacavalli; Anna Maria Cafro; Marzia Varettoni; Francesca Gay; Enrica Morra; Mario Lazzarino
Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.
Leukemia research 2009;33(9):e145-9.
2009: Shaji Kumar; Sergio Giralt; Edward A Stadtmauer; Jean-Luc Harousseau; Antonio Palumbo; William Bensinger; Raymond Comenzo; Suzanne Lentzsch; Nikhil Munshi; Ruben Niesvizky; Jesús San Miguel; Heinz Ludwig; Leif Bergsagel; Joan Blade; Sagar Lonial; Kenneth C Anderson; Patrizia Tosi; Pieter Sonneveld; Orhan Sezer; David H Vesole; Michele Cavo; Hermann Einsele; Paul G Richardson; Brian G M Durie; S Vincent Rajkumar
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Blood 2009;114(9):1729-35.
2009: Manuela M Giarin; Luisa Giaccone; Roberto Sorasio; Christian Sfiligoi; Barbara Amoroso; Federica Cavallo; Alessia Cipriani; Antonio Palumbo; Mario Boccadoro
Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma.
Clinical chemistry 2009;55(8):1510-6.
2009: Benedetto Bruno; Marcello Rotta; Francesca Patriarca; Daniele Mattei; Bernardino Allione; Fabrizio Carnevale-Schianca; Roberto Sorasio; Alessandro Rambaldi; Marco Casini; Matteo Parma; Pasqua Bavaro; Francesco Onida; Alessandro Busca; Luca Castagna; Edoardo Benedetti; Anna Paola Iori; Luisa Giaccone; Antonio Palumbo; Paolo Corradini; Renato Fanin; David Maloney; Rainer Storb; Ileana Baldi; Umberto Ricardi; Mario Boccadoro
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo.
Blood 2009;113(14):3375-82.
2009: Antonio Palumbo; Patrizia Falco; Antonietta Falcone; Giulia Benevolo; Letizia Canepa; Francesca Gay; Alessandra Larocca; Valeria Magarotto; Alessandro Gozzetti; Annalisa Luraschi; Fortunato Morabito; Andrea Nozza; Robert D Knight; Jerome B Zeldis; Mario Boccadoro; Maria Teresa Petrucci
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
Clinical lymphoma & myeloma 2009;9(2):145-50.
2009: Efstathios Kastritis; Antonio Palumbo; Meletios A Dimopoulos
Treatment of relapsed/refractory multiple myeloma.
Seminars in hematology 2009;46(2):143-57.
2009: Antonio Palumbo; S V Rajkumar
Treatment of newly diagnosed myeloma.
Leukemia 2009;23(3):449-56.
2009: Antonio Palumbo; Meletios Dimopoulos; Jesus San Miguel; Jean-Luc Harousseau; Michel Attal; Mohamad Hussein; Stefan Knop; Heinz Ludwig; Marie von Lilienfeld-Toal; Pieter Sonneveld
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
Blood reviews 2009;23(2):87-93.
2009: Constantine S Mitsiades; Cecile Rouleau; Cinara Echart; Krishna Menon; Beverly Teicher; Maria Distaso; Antonio Palumbo; Mario Boccadoro; Kenneth C Anderson; Massimo Iacobelli; Paul G Richardson
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1210-21.
2009: A Dispenzieri; R Kyle; G Merlini; J S Miguel; Heinz Ludwig; R Hajek; Antonio Palumbo; Sundar Jagannath; J Blade; Sagar Lonial; M Dimopoulos; R Comenzo; H Einsele; Bart Barlogie; Kenneth C Anderson; M Gertz; Jean-Luc Harousseau; M Attal; P Tosi; Pieter Sonneveld; Mario Boccadoro; G Morgan; Paul G Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Leukemia 2009;23(2):215-24.
2009: Francesca Patriarca; Maria Teresa Petrucci; Sara Bringhen; Luca Baldini; Tommaso Caravita; Paolo Corradini; Alessandro Corso; Francesco Di Raimondo; Antonietta Falcone; Felicetto Ferrara; Fortunato Morabito; Pellegrino Musto; Massimo Offidani; Mario Petrini; Rita Rizzi; Gianpietro Semenzato; Patrizia Tosi; Angelo Vacca; Michele Cavo; Mario Boccadoro; Antonio Palumbo
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts.
European journal of haematology 2009;82(2):93-105.
2009: Antonio Palumbo; Francesca Gay
How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():566-77.
2008: Vittorio Montefusco; Francesca Gay; Francesco Spina; Rosalba Miceli; Massimo Maniezzo; Maria Teresa Ambrosini; Lucia Farina; Sheila Piva; Antonio Palumbo; Mario Boccadoro; Paolo Corradini
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates.
Leukemia & lymphoma 2008;49(11):2156-62.
2008: Antonio Palumbo; Sara Bringhen; Anna Marina Liberati; Tommaso Caravita; Antonietta Falcone; Vincenzo Callea; Marco Montanaro; Roberto Ria; Antonio Capaldi; Renato Zambello; Giulia Benevolo; Daniele Derudas; Fausto Dore; Federica Cavallo; Francesca Gay; Patrizia Falco; Giovannino Ciccone; Pellegrino Musto; Michele Cavo; Mario Boccadoro
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
Blood 2008;112(8):3107-14.
2008: Pellegrino Musto; Fiorella D'Auria; Giuseppe Pietrantuono; Sara Bringhen; Fortunato Morabito; Francesco Di Raimondo; Samantha Pozzi; Stefano Sacchi; Mario Boccadoro; Antonio Palumbo
Role of thalidomide in previously untreated patients with multiple myeloma.
Expert review of anticancer therapy 2008;8(10):1569-80.
2008: Pellegrino Musto; Maria Teresa Petrucci; Sara Bringhen; Tommasina Guglielmelli; Tommaso Caravita; Velia Bongarzoni; Alessandro Andriani; Giovanni D'Arena; Enrico Balleari; Giuseppe Pietrantuono; Mario Boccadoro; Antonio Palumbo
A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma.
Cancer 2008;113(7):1588-95.
2008: Flavia Pichiorri; Sung-Suk Suh; marco ladetto; Michael Kuehl; Tiziana Palumbo; Daniela Drandi; Cristian Taccioli; nicola zanesi; Hansjuerg Alder; John Patrick Hagan; Reinhold Munker; Stefano Volinia; Mario Boccadoro; Ramiro Garzon; Antonio Palumbo; Rami I Aqeilan; Carlo M Croce
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(35):12885-90.
2008: Antonio Palumbo; Valeria Magarotto; Francesca Gay; Patrizia Falco; Sara Bringhen; Mario Boccadoro
Update on recent developments for patients with newly diagnosed multiple myeloma.
Annals of the New York Academy of Sciences 2008;1138():19-21.
2008: Jesús F San Miguel; Rudolf Schlag; Nuriet K Khuageva; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Maria T Petrucci; Antonio Palumbo; Olga S Samoilova; Anna Dmoszynska; Kudrat M Abdulkadyrov; Rik Schots; Bin Jiang; Maria-Victoria Mateos; Kenneth C Anderson; Dixie Esseltine; Kevin Liu; Andrew Cakana; Helgi van de Velde; Paul G Richardson
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
The New England journal of medicine 2008;359(9):906-17.
2008: A Larocca; Federica Cavallo; V Magarotto; Davide Rossi; F Patriarca; Mario Boccadoro; Antonio Palumbo
Defibrotide: a review on clinical use and future development.
Expert opinion on biological therapy 2008;8(8):1201-12.
2008: Sonia Vallet; Antonio Palumbo; Noopur Raje; Mario Boccadoro; Kenneth C Anderson
Thalidomide and lenalidomide: Mechanism-based potential drug combinations.
Leukemia & lymphoma 2008;49(7):1238-45.
2008: Patrizia Falco; Federica Cavallo; Alessandra Larocca; Anna Marina Liberati; Pellegrino Musto; Mario Boccadoro; Antonio Palumbo
Lenalidomide and its role in the management of multiple myeloma.
Expert review of anticancer therapy 2008;8(6):865-74.
2008: Antonio Palumbo; Francesca Gay; Sara Bringhen; Antonietta Falcone; Norbert Pescosta; V Callea; Tommaso Caravita; F Morabito; V Magarotto; M Ruggeri; Ilaria Avonto; Pellegrino Musto; N Cascavilla; Benedetto Bruno; Mario Boccadoro
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1160-5.
2008: Antonio Palumbo; Jesús San Miguel; Pieter Sonneveld; Philippe Moreau; Johannes Drach; Gareth Morgan; Hermann Einsele
Lenalidomide: a new therapy for multiple myeloma.
Cancer treatment reviews 2008;34(3):283-91.
2008: Heinz Ludwig; Brian G M Durie; Vanessa Bolejack; Ingemar Turesson; Robert A Kyle; Joan Blade; Rafael Fonseca; Meletios Dimopoulos; Kazuyuki Shimizu; Jesus San Miguel; Jan Westin; Jean-Luc Harousseau; Meral Beksac; Mario Boccadoro; Antonio Palumbo; Bart Barlogie; Chaim Shustik; Michele Cavo; Philip R Greipp; Douglas Joshua; Michel Attal; Pieter Sonneveld; John Crowley
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
Blood 2008;111(8):4039-47.
2008: Antonio Palumbo; Thierry Facon; Pieter Sonneveld; Joan Bladè; Massimo Offidani; Francesca Gay; Philippe Moreau; Anders Waage; Andrew Spencer; Heinz Ludwig; Mario Boccadoro; Jean-Luc Harousseau
Thalidomide for treatment of multiple myeloma: 10 years later.
Blood 2008;111(8):3968-77.
2008: Antonio Palumbo; Valeria Magarotto; Alessandra Larocca; Sara Bringhen; Patrizia Falco; Francesco Di Raimondo; Luca Baldini; Mario Boccadoro
Treatment of newly diagnosed multiple myeloma.
Current hematologic malignancy reports 2008;3(2):107-14.
2008: Smitha Patiyil Menon; S Vincent Rajkumar; Martha Lacy; Patrizia Falco; Antonio Palumbo
Thromboembolic events with lenalidomide-based therapy for multiple myeloma.
Cancer 2008;112(7):1522-8.
2008: Roberto Piva; Bruce Ruggeri; Michael Williams; Giulia Costa; Ilaria Tamagno; Dario Ferrero; Valentina Giai; Marta Coscia; Silvia Peola; Massimo Massaia; Gabriella Pezzoni; Cecilia Allievi; Nicoletta Pescalli; Mara Cassin; Stefano di Giovine; Paola Nicoli; Paola de Feudis; Ivan Strepponi; Ilaria Roato; Riccardo Ferracini; Benedetta Bussolati; Giovanni Camussi; Susan Jones-Bolin; Kathryn Hunter; Hugh Zhao; Antonino Neri; Antonio Palumbo; Celia Berkers; Huib Ovaa; Alberto Bernareggi; Giorgio Inghirami
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
Blood 2008;111(5):2765-75.
2008: Antonio Palumbo; S V Rajkumar; M A Dimopoulos; Paul G Richardson; J San Miguel; Bart Barlogie; Jean-Luc Harousseau; Jeffrey A Zonder; M Cavo; M Zangari; M Attal; A Belch; S Knop; D Joshua; O Sezer; Heinz Ludwig; D Vesole; J Bladé; R Kyle; J Westin; D Weber; S Bringhen; R Niesvizky; A Waage; M von Lilienfeld-Toal; Sagar Lonial; G J Morgan; Robert Z Orlowski; K Shimizu; Kenneth C Anderson; Mario Boccadoro; B G Durie; Pieter Sonneveld; M A Hussein
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Leukemia 2008;22(2):414-23.
2007: S Vincent Rajkumar; Antonio Palumbo
Management of newly diagnosed myeloma.
Hematology/oncology clinics of North America 2007;21(6):1141-56, ix-x.
2007: Antonio Palumbo; Mario Boccadoro
A new standard of care for elderly patients with myeloma.
Lancet 2007;370(9594):1191-2.
2007: Antonio Palumbo; Patrizia Falco; Paolo Corradini; Antonietta Falcone; Francesco Di Raimondo; Nicola Giuliani; Claudia Crippa; Giovannino Ciccone; Paola Omedè; Maria Teresa Ambrosini; Francesca Gay; Sara Bringhen; Pellegrino Musto; Robin Foà; Robert Knight; Jerome B Zeldis; Mario Boccadoro; Maria Teresa Petrucci
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4459-65.
2007: Antonio Palumbo; Sara Bringhen; Patrizia Falco; Federica Cavallo; Maria Teresa Ambrosini; Ilaria Avonto; Francesca Gay; Tommaso Caravita; Benedetto Bruno; Mario Boccadoro
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
Cancer 2007;110(4):824-9.
2007: Federica Cavallo; Mario Boccadoro; Antonio Palumbo
Review of thalidomide in the treatment of newly diagnosed multiple myeloma.
Therapeutics and clinical risk management 2007;3(4):543-52.
2007: Patrizia Falco; Sara Bringhen; Ilaria Avonto; Francesca Gay; Fortunato Morabito; Mario Boccadoro; Antonio Palumbo
Melphalan and its role in the management of patients with multiple myeloma.
Expert review of anticancer therapy 2007;7(7):945-57.
2007: Pellegrino Musto; Fausto Rossini; Francesca Gay; Vincenzo Pitini; Tommasina Guglielmelli; Giovanni D'Arena; Felicetto Ferrara; Nunzio Filardi; Roberto Guariglia; Antonio Palumbo
Efficacy and safety of bortezomib in patients with plasma cell leukemia.
Cancer 2007;109(11):2285-90.
2007: Massimo Offidani; Sara Bringhen; Laura Corvatta; Patrizia Falco; Monica Marconi; Ilaria Avonto; Maria-Novella Piersantelli; Claudia Polloni; Mario Boccadoro; Pietro Leoni; Antonio Palumbo
Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.
European journal of haematology 2007;78(4):297-302.
2007: Antonio Palumbo; Maria Teresa Ambrosini; Giulia Benevolo; Patrizia Pregno; Norbert Pescosta; Vincenzo Callea; Clotilde Cangialosi; Tommaso Caravita; Fortunato Morabito; Pellegrino Musto; Sara Bringhen; Patrizia Falco; Ilaria Avonto; Federica Cavallo; Mario Boccadoro
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
Blood 2007;109(7):2767-72.
2007: Benedetto Bruno; Marcello Rotta; Francesca Patriarca; Nicola Mordini; Bernardino Allione; Fabrizio Carnevale-Schianca; Luisa Giaccone; Roberto Sorasio; Paola Omedè; Ileana Baldi; Sara Bringhen; Massimo Massaia; Massimo Aglietta; Alessandro Levis; Andrea Gallamini; Renato Fanin; Antonio Palumbo; Rainer Storb; Giovannino Ciccone; Mario Boccadoro
A comparison of allografting with autografting for newly diagnosed myeloma.
The New England journal of medicine 2007;356(11):1110-20.
2007: Federica Cavallo; Maria Teresa Ambrosini; Cecilia Rus; Mario Boccadoro; Antonio Palumbo
The treatment of the elderly multiple myeloma patients.
Leukemia & lymphoma 2007;48(3):469-80.
2006: Sara Bringhen; Ilaria Avonto; Valeria Magarotto; Mario Boccadoro; Antonio Palumbo
Investigational treatments for multiple myeloma.
Expert opinion on investigational drugs 2006;15(12):1565-82.
2006: Antonio Palumbo; Cecilia Rus; J B Zeldis; F Rodeghiero; Mario Boccadoro
Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1842-5.
2006: Tommaso Caravita; Paolo De Fabritiis; Antonio Palumbo; Sergio Amadori; Mario Boccadoro
Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.
Nature clinical practice. Oncology 2006;3(7):374-87.
2006: Antonio Palumbo; Ilaria Avonto; Benedetto Bruno; Antonietta Falcone; Potito Rosario Scalzulli; Maria Teresa Ambrosini; Sara Bringhen; Francesca Gay; Cecilia Rus; Federica Cavallo; Patrizia Falco; Massimo Massaia; Pellegrino Musto; Mario Boccadoro
Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.
Clinical lymphoma & myeloma 2006;6(6):475-7.
2006: Antonio Palumbo; Ilaria Avonto; Benedetto Bruno; Maria Teresa Ambrosini; Sara Bringhen; Federica Cavallo; Patrizia Falco; Mario Boccadoro
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
European journal of haematology 2006;76(4):273-7.
2006: Antonio Palumbo; Sara Bringhen; Tommaso Caravita; Emanuela Merla; Vincenzo Capparella; Vincenzo Callea; Clotilde Cangialosi; Mariella Grasso; Fausto Rossini; Monica Galli; Lucio Catalano; Elena Zamagni; Maria Teresa Petrucci; Valerio De Stefano; Manuela Ceccarelli; Maria Teresa Ambrosini; Ilaria Avonto; Patrizia Falco; Giovannino Ciccone; Anna Marina Liberati; Pellegrino Musto; Mario Boccadoro
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
Lancet 2006;367(9513):825-31.
2006: Pellegrino Musto; Antonietta Falcone; Grazia Sanpaolo; Tommasina Guglielmelli; Renato Zambello; Enrico Balleari; Lucio Catalano; Mauro Spriano; Federica Cavallo; Antonio La Sala; Saverio Mantuano; Michele Nobile; Lorella Melillo; Potito Rosario Scalzulli; Matteo Dell'Olio; Carlo Bodenizza; Michele Mario Greco; Angelo Michele Carella; Emanuela Merla; Angelo Michele Carella; Mario Boccadoro; Nicola Cascavilla; Antonio Palumbo
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide.
Leukemia research 2006;30(3):283-5.
2005: Antonio Palumbo; Patrizia Falco; Maria Teresa Ambrosini; Maria Teresa Petrucci; Pellegrino Musto; Tommaso Caravita; Patrizia Pregno; Alessandra Bertola; Federica Cavallo; Giovannino Ciccone; Mario Boccadoro
Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant.
European journal of haematology 2005;75(5):391-5.
2005: Antonio Palumbo; Alessandra Bertola; Pellegrino Musto; Tommaso Caravita; Vincenzo Callea; Martina Nunzi; Mariella Grasso; Patrizia Falco; Clotilde Cangialosi; Mario Boccadoro
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
Cancer 2005;104(7):1428-33.
2005: marco ladetto; Sonia Vallet; Andreas Trojan; Maria Dell'Aquila; Luigia Monitillo; Rosalba Rosato; Loredana Santo; Daniela Drandi; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Irene Ricca; Federica De Marco; Barbara Mantoan; Beata Bode-Lesniewska; Gloria Pagliano; Roberto Maurizio Francese; Alberto Rocci; Monica Astolfi; Mara Compagno; Sara Mariani; Laura Godio; Lydia Marino; Marina Ruggeri; Paola Omedè; Antonio Palumbo; Mario Boccadoro
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.
Blood 2005;105(12):4784-91.
2005: Antonio Palumbo; Maria Teresa Petrucci; Vito Michele Lauta; Pellegrino Musto; Tommaso Caravita; Anna Barbui; Martina Nunzi; Mario Boccadoro
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study.
Haematologica 2005;90(6):858-60.
2005: Kenneth C Anderson; Antonio Palumbo
Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
Oncology (Williston Park, N.Y.) 2005;19(4):447-50.
2005: Sara Mariani; M Muraro; F Pantaleoni; Francesca Fiore; Barbara Nuschak; Silvia Peola; Myriam Foglietta; Antonio Palumbo; Marta Coscia; B Castella; Benedetto Bruno; Raffaello Bertieri; L Boano; Mario Boccadoro; Massimo Massaia
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.
Leukemia 2005;19(4):664-70.
2005: Mario Boccadoro; Joan Blade; Michel Attal; Antonio Palumbo
The future role of thalidomide in multiple myeloma.
Acta haematologica 2005;114 Suppl 1():18-22.
2004: Antonio Palumbo; Sara Bringhen; Maria Teresa Petrucci; Pellegrino Musto; Fausto Rossini; Martina Nunzi; Vito Michele Lauta; Cesare Bergonzi; Anna Barbui; Tommaso Caravita; Antonio Capaldi; Patrizia Pregno; Tommasina Guglielmelli; Mariella Grasso; Vincenzo Callea; Alessandra Bertola; Federica Cavallo; Patrizia Falco; Cecilia Rus; Massimo Massaia; Franco Mandelli; Angelo Michele Carella; Enrico Pogliani; Anna Marina Liberati; Franco Dammacco; Giovannino Ciccone; Mario Boccadoro
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
Blood 2004;104(10):3052-7.
2004: Cecilia Rus; Mario Bazzan; Antonio Palumbo; Sara Bringhen; Mario Boccadoro
Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis.
Journal of thrombosis and haemostasis : JTH 2004;2(11):2063-5.
2004: Benedetto Bruno; Marcello Rotta; Luisa Giaccone; Massimo Massaia; Alessandra Bertola; Antonio Palumbo; Mario Boccadoro
New drugs for treatment of multiple myeloma.
The lancet oncology 2004;5(7):430-42.
2004: Gianluca Isoardo; Mauro Bergui; Luca Durelli; Pierangelo Barbero; Mario Boccadoro; Alessandra Bertola; PALMA CIARAMITARO; Antonio Palumbo; Bruno Bergamasco; Dario Cocito
Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features.
Acta neurologica Scandinavica 2004;109(3):188-93.
2004: Patrizia Falco; Alessandra Bertola; Sara Bringhen; Federica Cavallo; Mario Boccadoro; Antonio Palumbo
Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(5):456-7.
2004: Antonio Palumbo; Alessandra Bertola; Patrizia Falco; Rosalba Rosato; Federica Cavallo; Luisa Giaccone; Sara Bringhen; Pellegrino Musto; Patrizia Pregno; Tommaso Caravita; Giovannino Ciccone; Mario Boccadoro
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(4):318-24.
2004: Antonio Palumbo; Sara Bringhen; Alessandra Bertola; Federica Cavallo; Patrizia Falco; Massimo Massaia; Benedetto Bruno; Cecilia Rus; Anna Barbui; Tommaso Caravita; Pellegrino Musto; Norbert Pescosta; Fausto Rossini; M Vignetti; Mario Boccadoro
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2)).
Leukemia 2004;18(1):133-8.
2003: marco ladetto; Daniela Drandi; Mara Compagno; Monica Astolfi; Federica Volpato; Claudia Voena; Anna Novarino; Berardino Pollio; Alfredo Addeo; Irene Ricca; Patrizia Falco; Federica Cavallo; Sonia Vallet; Paolo Corradini; Alessandro Pileri; Giacomo Tamponi; Antonio Palumbo; Oscar Bertetto; Mario Boccadoro; Corrado Tarella
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1398-403.
2002: Mario Boccadoro; Antonio Palumbo; Sara Bringhen; Franco Merletti; Giovannino Ciccone; Lorenzo Richiardi; Cecilia Rus; Alessandra Bertola; Luisa Giaccone; Paola Omedè; Pellegrino Musto
Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
Haematologica 2002;87(8):846-50.
2002: marco ladetto; Paola Omedè; Selina Sametti; John W Donovan; Monica Astolfi; Daniela Drandi; Federica Volpato; Luisa Giaccone; Fulvia Giaretta; Antonio Palumbo; Benedetto Bruno; Alessandro Pileri; John G Gribben; Mario Boccadoro
Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests.
Experimental hematology 2002;30(6):529-36.
2002: Mario Boccadoro; Antonio Palumbo
New developments and treatment in multiple myeloma: new drugs in the treatment of multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():55-8.
2001: Antonio Palumbo; Luisa Giaccone; Alessandra Bertola; Patrizia Pregno; Sara Bringhen; Cecilia Rus; S Triolo; Eugenio Gallo; Alessandro Pileri; Mario Boccadoro
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma.
Haematologica 2001;86(4):399-403.
2000: Antonio Palumbo; S Triolo; Luca Baldini; Vincenzo Callea; Antonio Capaldi; V De Stefano; Mariella Grasso; Marina Liberati; C Lotesoriere; R Marcenò; Filippo Marmont; Pellegrino Musto; Maria Teresa Petrucci; Mauro Spriano; Alessandro Pileri; Mario Boccadoro
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.
Haematologica 2000;85(5):508-13.
2000: Mario Boccadoro; P Omedé; Alida Dominietto; Antonio Palumbo; Sara Bringhen; Fulvia Giaretta; B Ortolano; S Triolo; Alessandro Pileri
Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
Bone marrow transplantation 2000;25(1):25-9.
1999: Mario Boccadoro; Corrado Tarella; Antonio Palumbo; C Argentino; S Triolo; Alida Dominietto; Vincenzo Callea; Vito Michele Lauta; Stefano Molica; Pellegrino Musto; Filippo Marmont; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.
Haematologica 1999;84(10):905-10.
1999: Antonio Palumbo; S Triolo; C Argentino; Sara Bringhen; Alida Dominietto; Cecilia Rus; Paola Omedè; Corrado Tarella; Alessandro Pileri; Mario Boccadoro
Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients.
Blood 1999;94(4):1248-53.
1999: Paolo Corradini; Claudia Voena; Corrado Tarella; Monica Astolfi; marco ladetto; Antonio Palumbo; Maria Teresa Van Lint; A Bacigalupo; A Santoro; Maurizio Musso; Ignazio Majolino; Mario Boccadoro; Alessandro Pileri
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):208-15.
1998: Ignazio Majolino; Paolo Corradini; Rosanna Scimè; A Santoro; Corrado Tarella; AM Cavallaro; Antonio Palumbo; A Indovina; Daniele Caracciolo; Mario Boccadoro; R Marcenò; Alessandro Pileri
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1998;22(5):449-55.
1997: Paola Omedè; Corrado Tarella; Antonio Palumbo; C Argentino; Daniele Caracciolo; Paolo Corradini; Alida Dominietto; Fulvia Giaretta; R Ravaglia; R Triolo; S Triolo; Alessandro Pileri; Mario Boccadoro
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses.
British journal of haematology 1997;99(3):685-91.
1997: Mario Boccadoro; Antonio Palumbo; C Argentino; Alida Dominietto; R Frieri; Giuseppe Avvisati; B Comotti; Vito Michele Lauta; Marina Liberati; Filippo Marmont; Pellegrino Musto; M Tribalto; Alessandro Pileri
Conventional induction treatments do not influence overall survival in multiple myeloma.
British journal of haematology 1997;96(2):333-7.
1997: R Triolo; Paola Omedè; Fulvia Giaretta; R Ravaglia; Silvano Battaglio; Antonio Palumbo; Alida Dominietto; C Argentino; S Triolo; Alessandro Pileri; Mario Boccadoro
Cytofluorimetric evaluation of plasma cell proliferative activity in monoclonal gammopathies.
European journal of histochemistry : EJH 1997;41 Suppl 2():57-8.
1997: Antonio Palumbo; Alessandro Pileri; S Triolo; Paola Omedè; Benedetto Bruno; G Ciravegna; M Galliano; R Frieri; Mario Boccadoro
Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patients.
Bone marrow transplantation 1997;19(1):23-9.
1996: A Pileri; Antonio Palumbo; Mario Boccadoro
Current therapeutic options for multiple myeloma.
Haematologica 1996;81(4):291-4.
1995: Antonio Palumbo; Benedetto Bruno; Mario Boccadoro; Alessandro Pileri
Interferon-gamma in multiple myeloma.
Leukemia & lymphoma 1995;18(3-4):215-9.
1995: Antonio Palumbo; Silvano Battaglio; P Napoli; Benedetto Bruno; Paola Omedè; Mario Boccadoro; Alessandro Pileri
Retinoic acid inhibits the growth of human myeloma cells in vitro.
British journal of haematology 1995;89(3):555-60.
1994: Meletios A Dimopoulos; Antonio Palumbo; Kay Delasalle; Raymond Alexanian
Primary plasma cell leukaemia.
British journal of haematology 1994;88(4):754-9.
1994: Antonio Palumbo; Mario Boccadoro; Benedetto Bruno; S Triolo; Alessandro Pileri
Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma.
Haematologica 1994;79(6):513-8.
1994: Antonio Palumbo; Silvano Battaglio; P Napoli; Paola Omedè; A Fusaro; Benedetto Bruno; Mario Boccadoro; Alessandro Pileri
Recombinant interferon-gamma inhibits the in vitro proliferation of human myeloma cells.
British journal of haematology 1994;86(4):726-32.
1994: Antonio Palumbo; Benedetto Bruno; S Triolo; Mario Boccadoro; Alessandro Pileri
Recombinant interferon-gamma in a patient with multiple myeloma.
European journal of cancer (Oxford, England : 1990) 1994;30A(11):1731.
1993: Paolo Corradini; marco ladetto; Claudia Voena; Antonio Palumbo; Giorgio Inghirami; Daniel M Knowles; Mario Boccadoro; Alessandro Pileri
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
Blood 1993;81(10):2708-13.
1993: Alessandro Pileri; Antonio Palumbo; Mario Boccadoro
Multiple myeloma: a tailored therapy for elderly patients.
Hematological oncology 1993;11 Suppl 1():67-72.
1993: Antonio Palumbo; Mario Boccadoro; L A Garino; G Gallone; R Frieri; Alessandro Pileri
Interferon plus glucocorticoids as intensified maintenance therapy prolongs tumor control in relapsed myeloma.
Acta haematologica 1993;90(2):71-6.
1992: Antonio Palumbo; Silvano Battaglio; Monica Astolfi; R Frieri; Mario Boccadoro; Alessandro Pileri
Multiple independent immunoglobulin class-switch recombinations occurring within the same clone in myeloma.
British journal of haematology 1992;82(4):676-80.
1992: Corrado Tarella; Paola Omedè; Mario Boccadoro; Antonio Palumbo; Silvano Battaglio; Alessandro Pileri
Early disappearance of murine plasmocytoma stem cells in long-term bone marrow culture.
Leukemia research 1992;16(8):743-50.
1992: Antonio Palumbo; Mario Boccadoro; L A Garino; G Gallone; R Frieri; Alessandro Pileri
Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.
European journal of haematology 1992;49(2):93-7.
1991: Mario Boccadoro; Silvano Battaglio; Paola Omedè; Antonio Palumbo; A Fusaro; R Frieri; G Gallone; R Polloni; R Mosso; P G De Filippi
Increased serum neopterin concentration as indicator of disease severity and poor survival in multiple myeloma.
European journal of haematology 1991;47(4):305-9.
1991: Mario Boccadoro; Silvano Battaglio; Umberto Dianzani; R Frieri; G Gallone; Massimo Massaia; Paola Omedè; Antonio Palumbo; Alessandro Pileri
[Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications].
Haematologica 1991;76 Suppl 3():100-6.
1991: Antonio Palumbo; Paolo Corradini; Silvano Battaglio; Paola Omedè; R Coda; Mario Boccadoro; Alessandro Pileri
Dual rearrangement of immunoglobulin and T-cell receptor gene in a case of T-cell hairy-cell leukemia.
European journal of haematology 1991;46(2):71-6.
1990: Antonio Palumbo; A L Garino; R Frieri; G Gallone; Mario Boccadoro; Alessandro Pileri
Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy.
Haematologica 1990;75(6):576-8.
1990: Paolo Corradini; Antonio Palumbo; Silvano Battaglio; G Ponzio; Mario Boccadoro; Alessandro Pileri
Analysis of the breakpoint cluster region in essential thrombocythemia.
Haematologica 1990;75(6):573-5.
1990: Antonio Palumbo; Mario Boccadoro; Silvano Battaglio; Paolo Corradini; Philip Tsichlis; K Huebner; Alessandro Pileri; C M Croce
Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas.
Cancer research 1990;50(20):6478-82.
1989: Mario Boccadoro; A Bianchi; Umberto Dianzani; R Frieri; G Gallone; Massimo Massaia; P Omede; Antonio Palumbo; Alessandro Pileri
[Prognostic factors in multiple myeloma].
Haematologica 1989;74(5 Suppl):347-57.
1989: Antonio Palumbo; Alessandro Pileri; Umberto Dianzani; Massimo Massaia; Mario Boccadoro; B Calabretta
Altered expression of growth-regulated protooncogenes in human malignant plasma cells.
Cancer research 1989;49(17):4701-4.
1989: Antonio Palumbo; Mario Boccadoro; Silvano Battaglio; Paolo Corradini; B Giovinazzo; Gian Carlo Avanzi; G Ponzio
Philadelphia-positive thrombocythemia with a complex translocation involving chromosomes 9, 15, and 22.
Cancer genetics and cytogenetics 1989;39(1):77-80.
1989: Antonio Palumbo; Alessandro Pileri; Silvano Battaglio; Paola Omedè; V Redoglia; Massimo Massaia; Umberto Dianzani; Mario Boccadoro
Monoclonal immunoglobulin gene rearrangement in peripheral lymphocytes of a patient with multiple myeloma.
Tumori 1989;75(1):1-3.
1988: Massimo Massaia; Alessandro Pileri; Mario Boccadoro; A Bianchi; Antonio Palumbo; Umberto Dianzani
The generation of alloreactive cytotoxic T lymphocytes requires the expression of ecto-5'nucleotidase activity.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(11):3768-75.
1988: Umberto Dianzani; Alessandro Pileri; Mario Boccadoro; Antonio Palumbo; P Pioppo; A Bianchi; A Camponi; G Fossati; Silvano Battaglio; Massimo Massaia
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status.
Blood 1988;72(3):1064-8.
1983: L Matera; R Foa; Filippo Marmont; Massimo Massaia; Antonio Palumbo; L Pegoraro
Changes in SRBC binding capacity and T-surface antigen expression on human peripheral blood lymphocytes stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Journal of clinical & laboratory immunology 1983;12(1):57-61.
1982: Antonio Palumbo; B Giovinazzo; Filippo Marmont; Giovanni Garbarino; F Paolino; Luigi Pegoraro
[Expression of HLA-DR structure and a membrane-specific antigen by a granulocytopoietic line of acute leukemic blast cells].
Bollettino della Società italiana di biologia sperimentale 1982;58(6):271-4.